Aurora Cannabis Future Growth
Future criteria checks 1/6
Aurora Cannabis is forecast to grow earnings and revenue by 79.2% and 12.1% per annum respectively. EPS is expected to grow by 79.2% per annum. Return on equity is forecast to be -1.1% in 3 years.
Key information
79.2%
Earnings growth rate
79.2%
EPS growth rate
| Pharmaceuticals earnings growth | 75.3% |
| Revenue growth rate | 12.1% |
| Future return on equity | -1.1% |
| Analyst coverage | Good |
| Last updated | 27 Jun 2024 |
Recent future growth updates
Recent updates
Aurora Cannabis Inc.'s (TSE:ACB) Share Price Is Still Matching Investor Opinion Despite 29% Slump
Jun 27
Why Aurora Cannabis' (TSE:ACB) Earnings Are Weaker Than They Seem
Feb 15Is Aurora Cannabis (TSE:ACB) Using Too Much Debt?
Sep 12Investors Holding Back On Aurora Cannabis Inc. (TSE:ACB)
Jun 13Is Aurora Cannabis (TSE:ACB) Using Debt Sensibly?
Jan 15Downgrade: Here's How Analysts See Aurora Cannabis Inc. (TSE:ACB) Performing In The Near Term
Nov 13Does Aurora Cannabis (TSE:ACB) Have A Healthy Balance Sheet?
Sep 22Aurora Cannabis (TSE:ACB) Is Carrying A Fair Bit Of Debt
Apr 21Is Aurora Cannabis (TSE:ACB) Using Too Much Debt?
Jan 05A Look At The Intrinsic Value Of Aurora Cannabis Inc. (TSE:ACB)
Nov 13Is Aurora Cannabis (TSE:ACB) Weighed On By Its Debt Load?
Oct 04Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2027 | 373 | -6 | N/A | N/A | 2 |
| 3/31/2026 | 342 | -5 | 17 | 30 | 5 |
| 3/31/2025 | 301 | -22 | -26 | -25 | 6 |
| 3/31/2024 | 270 | -55 | -85 | -69 | N/A |
| 12/31/2023 | 276 | 411 | -99 | -83 | N/A |
| 9/30/2023 | 273 | 374 | -153 | -139 | N/A |
| 6/30/2023 | 258 | 331 | -149 | -139 | N/A |
| 3/31/2023 | 224 | -793 | -163 | -142 | N/A |
| 12/31/2022 | 212 | -1,748 | -181 | -157 | N/A |
| 9/30/2022 | 210 | -1,757 | -152 | -118 | N/A |
| 6/30/2022 | 221 | -1,718 | -142 | -110 | N/A |
| 3/31/2022 | 226 | -1,233 | -98 | -64 | N/A |
| 12/31/2021 | 231 | -381 | -122 | -82 | N/A |
| 9/30/2021 | 238 | -607 | -165 | -124 | N/A |
| 6/30/2021 | 245 | -692 | -264 | -211 | N/A |
| 3/31/2021 | 257 | -2,387 | -357 | -284 | N/A |
| 12/31/2020 | 275 | -2,359 | -430 | -285 | N/A |
| 9/30/2020 | 263 | -3,342 | -614 | -357 | N/A |
| 6/30/2020 | 269 | -3,231 | -691 | -342 | N/A |
| 3/31/2020 | 299 | -1,405 | -778 | -293 | N/A |
| 12/31/2019 | 291 | -1,430 | -787 | -289 | N/A |
| 9/30/2019 | 290 | -385 | -667 | -218 | N/A |
| 6/30/2019 | 246 | -294 | -606 | -192 | N/A |
| 3/31/2019 | 168 | -211 | -519 | -233 | N/A |
| 12/31/2018 | 119 | -72 | -439 | -206 | N/A |
| 9/30/2018 | 77 | 174 | -334 | -146 | N/A |
| 6/30/2018 | 55 | 72 | -219 | -82 | N/A |
| 3/31/2018 | 42 | -13 | -146 | -35 | N/A |
| 12/31/2017 | 31 | 7 | N/A | -16 | N/A |
| 9/30/2017 | 23 | -4 | N/A | -15 | N/A |
| 6/30/2017 | 18 | -13 | N/A | -13 | N/A |
| 3/31/2017 | 13 | -16 | N/A | -17 | N/A |
| 12/31/2016 | 8 | -13 | N/A | -11 | N/A |
| 9/30/2016 | 5 | -10 | N/A | -9 | N/A |
| 6/30/2016 | 1 | -6 | N/A | -7 | N/A |
| 3/31/2016 | 0 | 0 | N/A | -5 | N/A |
| 12/31/2015 | N/A | -3 | N/A | -3 | N/A |
| 9/30/2015 | N/A | -10 | N/A | -3 | N/A |
| 6/30/2015 | N/A | -10 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ACB is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ACB is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ACB is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ACB's revenue (12.1% per year) is forecast to grow faster than the Canadian market (7.3% per year).
High Growth Revenue: ACB's revenue (12.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ACB is forecast to be unprofitable in 3 years.